Quality of Life in Patients with End-Stage Renal Disease Undergoing Hemodialysis.

Elżbieta Dembowska,Ewa Gabrysz-Trybek,Grzegorz Trybek,Joanna Bladowska,Szymon Gacek,Aleksandra Jaroń

doi:10.3390/jcm11061584

Elżbieta Dembowska, Ewa Gabrysz-Trybek + Show 4 more

Open Access

https://doi.org/10.3390/jcm11061584

Copy DOI

Abstract

End-stage renal disease and hemodialysis therapy cause a number of changes, not only somatic but also psychosocial, including the patient’s perception and assessment of their quality of life. The literature describes predispositions to pathologies in the oral mucosa, craniofacial bones, teeth, and surrounding tissues in hemodialysis patients. This study aimed to determine the quality of life of hemodialysis patients in comparison with healthy subjects. The study group consisted of 200 subjects: the HD group (hemodialysis patients, n = 100) and the K group (control group, n = 100). General health and oral status were assessed using the following indices: plaque index, gingival index, probing depth, and clinical adhesion level. The WHOQOL-BREF survey was performed to determine both groups’ overall quality of life. The results showed lower values of assessed quality-of-life parameters in hemodialysis patients compared to the control group, especially in the somatic sphere. General diseases such as oral mycosis, osteoporosis, rheumatoid arthritis, and coronary-artery disease negatively impact the perceived quality of life. There are numerous indications for comprehensive psychological care of hemodialysis patients due to their poor psychosocial status.

Highlights

Published: 13 March 2022End-stage renal disease and hemodialysis therapy result in a number of changes, somatic and psychosocial, such as the patient’s perception and assessment of their quality of life [1,2]
This study aimed to determine the quality of life of hemodialysis patients compared to healthy subjects
According to the design of the WHOQOL-BREF research tool, quality of life was summarized in terms of overall quality of life, satisfaction with health (Table 2), and four domains: somatic, psychological, social, and environmental (Table 3)

Summary

Introduction

End-stage renal disease and hemodialysis therapy result in a number of changes, somatic and psychosocial, such as the patient’s perception and assessment of their quality of life [1,2]. The success of hemodialysis therapy is the possibility of keeping the patient alive despite end-stage renal failure. Assessing patients’ quality of life allows the medical team to see the patient’s perspective holistically, not just paying attention to the patient’s diseases, and fosters physician–patient rapport building [1,3–5]. Sapilak et al and Majkowicz et al demonstrated the significant deterioration of patients’ quality of life due to dialysis treatment [1,2]. The increased risk of complications, morbidity, and mortality in patients on hemodialysis is associated with decreased quality of life. As patients are limited in these activities of daily living, both their physical and psychological quality of life is reduced [6]

Objectives

Methods

Results

Discussion

Conclusion